University of Aberdeen logo

AURA - Aberdeen University Research Archive

 

Efficacy of daratumumab combination regimen in patients with multiple myeloma : A combined analysis of phase III randomized controlled trials

Simple item page
dc.contributor.authorHtut, Thura W.
dc.contributor.authorThein, Kyaw Z.
dc.contributor.authorLawrie, Alastair
dc.contributor.authorTighe, Jane
dc.contributor.authorPreston, Gavin
dc.contributor.institutionUniversity of Aberdeen.Medical Educationen
dc.contributor.institutionUniversity of Aberdeen.Applied Medicineen
dc.contributor.institutionUniversity of Aberdeen.Medical Sciencesen
dc.date.accessioned2020-08-31T08:05:01Z
dc.date.available2020-08-31T08:05:01Z
dc.date.issued2020-07
dc.descriptionOpen Access via the Jis Wiley Agreementen
dc.description.statusPeer revieweden
dc.format.extent5
dc.format.extent878285
dc.identifier171250094
dc.identifier2b5a698b-4a1c-40cb-9d08-9e4da13a4c83
dc.identifier.citationHtut, T W, Thein, K Z, Lawrie, A, Tighe, J & Preston, G 2020, 'Efficacy of daratumumab combination regimen in patients with multiple myeloma : A combined analysis of phase III randomized controlled trials', eJHaem, vol. 1, no. 1, pp. 262-266. https://doi.org/10.1002/jha2.46en
dc.identifier.doi10.1002/jha2.46
dc.identifier.iss1en
dc.identifier.issn2688-6146
dc.identifier.otherRIS: urn:3340C2966E1E1C7F4B003185997A348C
dc.identifier.urihttps://hdl.handle.net/2164/15035
dc.identifier.vol1en
dc.language.isoeng
dc.relation.ispartofeJHaemen
dc.subjectdaratumumaben
dc.subjectmeta-analysisen
dc.subjectmultiple myelomaen
dc.subjectphase III randomized controlled trialsen
dc.subjectR Medicineen
dc.subject.lccRen
dc.titleEfficacy of daratumumab combination regimen in patients with multiple myeloma : A combined analysis of phase III randomized controlled trialsen
dc.typeJournal articleen

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Htut_etal_jha_efficacy_VOR.pdf
Size:
857.7 KB
Format:
Adobe Portable Document Format
Download

Collections

All research